> top > docs > PubMed:26347523 > annotations

PubMed:26347523 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-170 Sentence denotes Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways:
TextSentencer_T2 171-193 Sentence denotes A microarray analysis.
TextSentencer_T3 194-457 Sentence denotes Sclerotium rolfsii lectin (SRL) is a lectin isolated from fungus S. rolfsii and has high binding specificity toward the oncofetal Thomsen-Friedenreich carbohydrate antigen (Galβ1-3GalNAc-α-O-Ser/Thr, T or TF), which is expressed in more than 90% of human cancers.
TextSentencer_T4 458-626 Sentence denotes Our previous studies have shown that binding of SRL to human colon, breast and ovarian cancer cells induces cell apoptosis in vitro and suppresses tumor growth in vivo.
TextSentencer_T5 627-746 Sentence denotes This study investigated the SRL-mediated cell signaling in human colon cancer HT29 cells by mRNA and miRNA microarrays.
TextSentencer_T6 747-997 Sentence denotes It was found that SRL treatment results in altered expression of several hundred molecules including mitogen-activated protein kinase (MAPK) and c-JUN-associated, apoptosis-associated and cell cycle and DNA replication-associated signaling molecules.
TextSentencer_T7 998-1259 Sentence denotes Pathway analysis using GeneSpring 12.6.1 revealed that SRL treatment induces changes of MAPK and c-JUN-associated signaling pathways as early as 2 h while changes of cell cycle, DNA replication and apoptosis pathways were significantly affected only after 24 h.
TextSentencer_T8 1260-1367 Sentence denotes A significant change of cell miRNA expression was also observed after 12 h treatment of the cells with SRL.
TextSentencer_T9 1368-1476 Sentence denotes These changes were further validated by quantitative real time polymerase chain reaction and immunoblotting.
TextSentencer_T10 1477-1718 Sentence denotes This study thus suggests that the presence of SRL affects multiple signaling pathways in cancer cells with early effects on cell proliferation pathways associated with MAPK and c-JUN, followed by miRNA-associated cell activity and apoptosis.
TextSentencer_T11 1719-1831 Sentence denotes This provides insight information into the molecular mechanism of the anticancer activity of this fungal lectin.
T1 0-193 Sentence denotes Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.
T2 194-457 Sentence denotes Sclerotium rolfsii lectin (SRL) is a lectin isolated from fungus S. rolfsii and has high binding specificity toward the oncofetal Thomsen-Friedenreich carbohydrate antigen (Galβ1-3GalNAc-α-O-Ser/Thr, T or TF), which is expressed in more than 90% of human cancers.
T3 458-626 Sentence denotes Our previous studies have shown that binding of SRL to human colon, breast and ovarian cancer cells induces cell apoptosis in vitro and suppresses tumor growth in vivo.
T4 627-746 Sentence denotes This study investigated the SRL-mediated cell signaling in human colon cancer HT29 cells by mRNA and miRNA microarrays.
T5 747-997 Sentence denotes It was found that SRL treatment results in altered expression of several hundred molecules including mitogen-activated protein kinase (MAPK) and c-JUN-associated, apoptosis-associated and cell cycle and DNA replication-associated signaling molecules.
T6 998-1259 Sentence denotes Pathway analysis using GeneSpring 12.6.1 revealed that SRL treatment induces changes of MAPK and c-JUN-associated signaling pathways as early as 2 h while changes of cell cycle, DNA replication and apoptosis pathways were significantly affected only after 24 h.
T7 1260-1367 Sentence denotes A significant change of cell miRNA expression was also observed after 12 h treatment of the cells with SRL.
T8 1368-1476 Sentence denotes These changes were further validated by quantitative real time polymerase chain reaction and immunoblotting.
T9 1477-1718 Sentence denotes This study thus suggests that the presence of SRL affects multiple signaling pathways in cancer cells with early effects on cell proliferation pathways associated with MAPK and c-JUN, followed by miRNA-associated cell activity and apoptosis.
T10 1719-1831 Sentence denotes This provides insight information into the molecular mechanism of the anticancer activity of this fungal lectin.
T1 0-170 Sentence denotes Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways:
T2 171-193 Sentence denotes A microarray analysis.
T3 194-457 Sentence denotes Sclerotium rolfsii lectin (SRL) is a lectin isolated from fungus S. rolfsii and has high binding specificity toward the oncofetal Thomsen-Friedenreich carbohydrate antigen (Galβ1-3GalNAc-α-O-Ser/Thr, T or TF), which is expressed in more than 90% of human cancers.
T4 458-626 Sentence denotes Our previous studies have shown that binding of SRL to human colon, breast and ovarian cancer cells induces cell apoptosis in vitro and suppresses tumor growth in vivo.
T5 627-746 Sentence denotes This study investigated the SRL-mediated cell signaling in human colon cancer HT29 cells by mRNA and miRNA microarrays.
T6 747-997 Sentence denotes It was found that SRL treatment results in altered expression of several hundred molecules including mitogen-activated protein kinase (MAPK) and c-JUN-associated, apoptosis-associated and cell cycle and DNA replication-associated signaling molecules.
T7 998-1259 Sentence denotes Pathway analysis using GeneSpring 12.6.1 revealed that SRL treatment induces changes of MAPK and c-JUN-associated signaling pathways as early as 2 h while changes of cell cycle, DNA replication and apoptosis pathways were significantly affected only after 24 h.
T8 1260-1367 Sentence denotes A significant change of cell miRNA expression was also observed after 12 h treatment of the cells with SRL.
T9 1368-1476 Sentence denotes These changes were further validated by quantitative real time polymerase chain reaction and immunoblotting.
T10 1477-1718 Sentence denotes This study thus suggests that the presence of SRL affects multiple signaling pathways in cancer cells with early effects on cell proliferation pathways associated with MAPK and c-JUN, followed by miRNA-associated cell activity and apoptosis.
T11 1719-1831 Sentence denotes This provides insight information into the molecular mechanism of the anticancer activity of this fungal lectin.

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 519-524 http://purl.obolibrary.org/obo/MAT_0000526 denotes colon
T2 692-697 http://purl.obolibrary.org/obo/MAT_0000526 denotes colon

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 78-83 FMAID:68646 denotes cells
_T2 78-83 FMAID:169002 denotes cells
_T3 120-125 FMAID:198663 denotes genes
_T4 345-357 FMAID:82737 denotes carbohydrate
_T5 345-357 FMAID:197276 denotes carbohydrate
_T6 519-524 FMAID:14543 denotes colon
_T7 519-524 FMAID:104231 denotes colon
_T8 526-532 FMAID:9601 denotes breast
_T9 526-532 FMAID:97486 denotes breast
_T10 552-557 FMAID:169002 denotes cells
_T11 552-557 FMAID:68646 denotes cells
_T12 692-697 FMAID:14543 denotes colon
_T13 692-697 FMAID:104231 denotes colon
_T14 710-715 FMAID:169002 denotes cells
_T15 710-715 FMAID:68646 denotes cells
_T16 866-873 FMAID:67257 denotes protein
_T17 866-873 FMAID:165447 denotes protein
_T18 931-939 FMAID:86471 denotes and cell
_T19 931-939 FMAID:200932 denotes and cell
_T20 1352-1357 FMAID:68646 denotes cells
_T21 1352-1357 FMAID:169002 denotes cells
_T22 1573-1578 FMAID:68646 denotes cells
_T23 1573-1578 FMAID:169002 denotes cells

uniprot-human

Id Subject Object Predicate Lexical cue
T1 221-224 http://www.uniprot.org/uniprot/Q86TD4 denotes SRL
T2 506-509 http://www.uniprot.org/uniprot/Q86TD4 denotes SRL
T3 655-658 http://www.uniprot.org/uniprot/Q86TD4 denotes SRL
T4 765-768 http://www.uniprot.org/uniprot/Q86TD4 denotes SRL
T5 1053-1056 http://www.uniprot.org/uniprot/Q86TD4 denotes SRL
T6 1363-1366 http://www.uniprot.org/uniprot/Q86TD4 denotes SRL
T7 1523-1526 http://www.uniprot.org/uniprot/Q86TD4 denotes SRL
T8 399-401 http://www.uniprot.org/uniprot/P02787 denotes TF
T9 399-401 http://www.uniprot.org/uniprot/P13726 denotes TF
T10 894-897 http://www.uniprot.org/uniprot/P05412 denotes JUN
T11 1097-1100 http://www.uniprot.org/uniprot/P05412 denotes JUN
T12 1656-1659 http://www.uniprot.org/uniprot/P05412 denotes JUN

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 399-401 http://www.uniprot.org/uniprot/P20352 denotes TF

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 10-19 http://purl.bioontology.org/ontology/NCBITAXON/127244 denotes mechanism
T2 44-54 http://purl.bioontology.org/ontology/NCBITAXON/109383 denotes Sclerotium
T3 44-54 http://purl.bioontology.org/ontology/NCBITAXON/109384 denotes Sclerotium
T4 78-83 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T5 194-204 http://purl.bioontology.org/ontology/NCBITAXON/109383 denotes Sclerotium
T6 194-204 http://purl.bioontology.org/ontology/NCBITAXON/109384 denotes Sclerotium
T7 252-258 http://purl.bioontology.org/ontology/STY/T004 denotes fungus
T8 449-456 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancers
T9 545-551 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T10 552-557 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T11 698-704 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T12 710-715 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T13 1352-1357 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T14 1566-1572 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T15 1573-1578 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T16 1772-1781 http://purl.bioontology.org/ontology/NCBITAXON/127244 denotes mechanism

GO-BP

Id Subject Object Predicate Lexical cue
T1 106-125 http://purl.obolibrary.org/obo/GO_0010467 denotes expression of genes
T2 151-160 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T3 673-682 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T4 977-986 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T5 1112-1121 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T6 1544-1553 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T7 151-169 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathways
T8 1112-1130 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathways
T9 1544-1562 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathways
T10 571-580 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T11 571-580 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T12 910-919 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T13 910-919 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T14 1196-1205 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T15 1196-1205 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T16 1708-1717 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T17 1708-1717 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T18 611-617 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T19 848-865 http://purl.obolibrary.org/obo/GO_0045840 denotes mitogen-activated
T20 856-880 http://purl.obolibrary.org/obo/GO_0004691 denotes activated protein kinase
T21 856-880 http://purl.obolibrary.org/obo/GO_0004674 denotes activated protein kinase
T22 856-880 http://purl.obolibrary.org/obo/GO_0004713 denotes activated protein kinase
T23 856-880 http://purl.obolibrary.org/obo/GO_0034199 denotes activated protein kinase
T24 856-880 http://purl.obolibrary.org/obo/GO_0050321 denotes activated protein kinase
T25 856-880 http://purl.obolibrary.org/obo/GO_2000479 denotes activated protein kinase
T26 856-880 http://purl.obolibrary.org/obo/GO_0004860 denotes activated protein kinase
T27 882-886 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T28 1086-1090 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T29 1645-1649 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T30 935-945 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T31 1164-1174 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T32 935-965 http://purl.obolibrary.org/obo/GO_0044786 denotes cell cycle and DNA replication
T33 1164-1191 http://purl.obolibrary.org/obo/GO_0044786 denotes cell cycle, DNA replication
T34 935-965 http://purl.obolibrary.org/obo/GO_0006279 denotes cell cycle and DNA replication
T35 1164-1191 http://purl.obolibrary.org/obo/GO_0006279 denotes cell cycle, DNA replication
T36 935-965 http://purl.obolibrary.org/obo/GO_0033260 denotes cell cycle and DNA replication
T37 1164-1191 http://purl.obolibrary.org/obo/GO_0033260 denotes cell cycle, DNA replication
T38 935-965 http://purl.obolibrary.org/obo/GO_1902292 denotes cell cycle and DNA replication
T39 1164-1191 http://purl.obolibrary.org/obo/GO_1902292 denotes cell cycle, DNA replication
T40 935-965 http://purl.obolibrary.org/obo/GO_1902294 denotes cell cycle and DNA replication
T41 1164-1191 http://purl.obolibrary.org/obo/GO_1902294 denotes cell cycle, DNA replication
T42 935-965 http://purl.obolibrary.org/obo/GO_1902969 denotes cell cycle and DNA replication
T43 1164-1191 http://purl.obolibrary.org/obo/GO_1902969 denotes cell cycle, DNA replication
T44 950-965 http://purl.obolibrary.org/obo/GO_0006260 denotes DNA replication
T45 1176-1191 http://purl.obolibrary.org/obo/GO_0006260 denotes DNA replication
T46 1601-1619 http://purl.obolibrary.org/obo/GO_0008283 denotes cell proliferation
T47 1690-1703 http://purl.obolibrary.org/obo/GO_0001775 denotes cell activity
T48 1690-1717 http://purl.obolibrary.org/obo/GO_0002904 denotes cell activity and apoptosis
T49 1690-1717 http://purl.obolibrary.org/obo/GO_0033034 denotes cell activity and apoptosis
T50 1690-1717 http://purl.obolibrary.org/obo/GO_1904037 denotes cell activity and apoptosis
T51 1690-1717 http://purl.obolibrary.org/obo/GO_0006924 denotes cell activity and apoptosis
T52 1690-1717 http://purl.obolibrary.org/obo/GO_0070238 denotes cell activity and apoptosis
T53 1690-1717 http://purl.obolibrary.org/obo/GO_0070234 denotes cell activity and apoptosis
T54 1690-1717 http://purl.obolibrary.org/obo/GO_0033027 denotes cell activity and apoptosis
T55 1690-1717 http://purl.obolibrary.org/obo/GO_0034352 denotes cell activity and apoptosis
T56 1690-1717 http://purl.obolibrary.org/obo/GO_0045850 denotes cell activity and apoptosis
T57 1690-1717 http://purl.obolibrary.org/obo/GO_1904651 denotes cell activity and apoptosis
T58 1690-1717 http://purl.obolibrary.org/obo/GO_1904710 denotes cell activity and apoptosis
T59 1695-1717 http://purl.obolibrary.org/obo/GO_0006915 denotes activity and apoptosis
T60 1695-1717 http://purl.obolibrary.org/obo/GO_0043065 denotes activity and apoptosis

GO-MF

Id Subject Object Predicate Lexical cue
T1 283-290 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T2 495-502 http://purl.obolibrary.org/obo/GO_0070026 denotes binding
T3 283-290 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T4 495-502 http://purl.obolibrary.org/obo/GO_0003680 denotes binding
T5 283-290 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T6 495-502 http://purl.obolibrary.org/obo/GO_0017091 denotes binding
T7 283-290 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T8 495-502 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T9 856-880 http://purl.obolibrary.org/obo/GO_0034237 denotes activated protein kinase
T10 856-880 http://purl.obolibrary.org/obo/GO_0051018 denotes activated protein kinase

GO-CC

Id Subject Object Predicate Lexical cue
T1 78-83 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T2 552-557 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T3 710-715 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T4 1352-1357 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T5 566-570 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T6 668-672 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T7 935-939 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T8 1164-1168 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T9 1284-1288 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T10 1601-1605 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T11 1690-1694 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T12 385-388 http://purl.obolibrary.org/obo/GO_0005790 denotes Ser
T13 920-939 http://purl.obolibrary.org/obo/GO_0009986 denotes associated and cell
T14 1679-1694 http://purl.obolibrary.org/obo/GO_0009986 denotes associated cell

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 519-524 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colon
T2 692-697 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colon
T3 526-532 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

GlycoBiology-MAT

Id Subject Object Predicate Lexical cue
T1 519-524 http://purl.obolibrary.org/obo/MAT_0000526 denotes colon
T2 692-697 http://purl.obolibrary.org/obo/MAT_0000526 denotes colon

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 389-392 "http://rdf.glycoinfo.org/glycan/G69371PB" denotes Thr
GlycanIUPAC_T2 389-392 "http://rdf.glycoinfo.org/glycan/G04439TG" denotes Thr
GlycanIUPAC_T3 389-392 "http://rdf.glycoinfo.org/glycan/G01418RR" denotes Thr
GlycanIUPAC_T4 389-392 "http://rdf.glycoinfo.org/glycan/G98605AX" denotes Thr
GlycanIUPAC_T5 389-392 "http://rdf.glycoinfo.org/glycan/G24282OK" denotes Thr
GlycanIUPAC_T6 389-392 "http://rdf.glycoinfo.org/glycan/G55879EK" denotes Thr
GlycanIUPAC_T7 389-392 "http://rdf.glycoinfo.org/glycan/G12116BQ" denotes Thr
GlycanIUPAC_T8 389-392 "http://rdf.glycoinfo.org/glycan/G54590PA" denotes Thr
GlycanIUPAC_T9 389-392 "http://rdf.glycoinfo.org/glycan/G31652HG" denotes Thr
GlycanIUPAC_T10 389-392 "http://rdf.glycoinfo.org/glycan/G15155WL" denotes Thr
GlycanIUPAC_T11 389-392 "http://rdf.glycoinfo.org/glycan/G52301ZX" denotes Thr
GlycanIUPAC_T12 389-392 "http://rdf.glycoinfo.org/glycan/G04075BC" denotes Thr
GlycanIUPAC_T13 389-392 "http://rdf.glycoinfo.org/glycan/G40829OF" denotes Thr
GlycanIUPAC_T14 389-392 "http://rdf.glycoinfo.org/glycan/G29274DI" denotes Thr
GlycanIUPAC_T15 389-392 "http://rdf.glycoinfo.org/glycan/G50601AY" denotes Thr
GlycanIUPAC_T16 389-392 "http://rdf.glycoinfo.org/glycan/G52865ZM" denotes Thr
GlycanIUPAC_T17 389-392 "http://rdf.glycoinfo.org/glycan/G73633QJ" denotes Thr
GlycanIUPAC_T18 389-392 "http://rdf.glycoinfo.org/glycan/G33319MN" denotes Thr
GlycanIUPAC_T19 389-392 "http://rdf.glycoinfo.org/glycan/G94717IQ" denotes Thr
GlycanIUPAC_T20 389-392 "http://rdf.glycoinfo.org/glycan/G50452ZL" denotes Thr
GlycanIUPAC_T21 389-392 "http://rdf.glycoinfo.org/glycan/G90753WM" denotes Thr
GlycanIUPAC_T22 389-392 "http://rdf.glycoinfo.org/glycan/G27898GL" denotes Thr
GlycanIUPAC_T23 389-392 "http://rdf.glycoinfo.org/glycan/G03827YH" denotes Thr
GlycanIUPAC_T24 389-392 "http://rdf.glycoinfo.org/glycan/G64500BA" denotes Thr
GlycanIUPAC_T25 389-392 "http://rdf.glycoinfo.org/glycan/G89743XV" denotes Thr
GlycanIUPAC_T26 389-392 "http://rdf.glycoinfo.org/glycan/G62576QG" denotes Thr
GlycanIUPAC_T27 389-392 "http://rdf.glycoinfo.org/glycan/G70212CQ" denotes Thr
GlycanIUPAC_T28 389-392 "http://rdf.glycoinfo.org/glycan/G74708KP" denotes Thr
GlycanIUPAC_T29 389-392 "http://rdf.glycoinfo.org/glycan/G02394PC" denotes Thr
GlycanIUPAC_T30 389-392 "http://rdf.glycoinfo.org/glycan/G57814GP" denotes Thr
GlycanIUPAC_T31 389-392 "http://rdf.glycoinfo.org/glycan/G81521LC" denotes Thr
GlycanIUPAC_T32 389-392 "http://rdf.glycoinfo.org/glycan/G42918SL" denotes Thr
GlycanIUPAC_T33 389-392 "http://rdf.glycoinfo.org/glycan/G95238FE" denotes Thr
GlycanIUPAC_T34 389-392 "http://rdf.glycoinfo.org/glycan/G28403TD" denotes Thr
GlycanIUPAC_T35 389-392 "http://rdf.glycoinfo.org/glycan/G30379UC" denotes Thr
GlycanIUPAC_T36 389-392 "http://rdf.glycoinfo.org/glycan/G83583TH" denotes Thr
GlycanIUPAC_T37 389-392 "http://rdf.glycoinfo.org/glycan/G59548EJ" denotes Thr
GlycanIUPAC_T38 389-392 "http://rdf.glycoinfo.org/glycan/G47410OV" denotes Thr
GlycanIUPAC_T39 389-392 "http://rdf.glycoinfo.org/glycan/G88663EK" denotes Thr
GlycanIUPAC_T40 389-392 "http://rdf.glycoinfo.org/glycan/G90684PG" denotes Thr
GlycanIUPAC_T41 389-392 "http://rdf.glycoinfo.org/glycan/G44881OW" denotes Thr
GlycanIUPAC_T42 389-392 "http://rdf.glycoinfo.org/glycan/G54691YO" denotes Thr
GlycanIUPAC_T43 389-392 "http://rdf.glycoinfo.org/glycan/G19289PT" denotes Thr
GlycanIUPAC_T44 389-392 "http://rdf.glycoinfo.org/glycan/G23779KC" denotes Thr
GlycanIUPAC_T45 389-392 "http://rdf.glycoinfo.org/glycan/G94729UX" denotes Thr
GlycanIUPAC_T46 389-392 "http://rdf.glycoinfo.org/glycan/G34038TZ" denotes Thr
GlycanIUPAC_T47 389-392 "http://rdf.glycoinfo.org/glycan/G90659JR" denotes Thr
GlycanIUPAC_T48 389-392 "http://rdf.glycoinfo.org/glycan/G74977VW" denotes Thr
GlycanIUPAC_T49 389-392 "http://rdf.glycoinfo.org/glycan/G42696WA" denotes Thr
GlycanIUPAC_T50 389-392 "http://rdf.glycoinfo.org/glycan/G82531XS" denotes Thr
GlycanIUPAC_T51 389-392 "http://rdf.glycoinfo.org/glycan/G47639GO" denotes Thr
GlycanIUPAC_T52 389-392 "http://rdf.glycoinfo.org/glycan/G69282NX" denotes Thr
GlycanIUPAC_T53 389-392 "http://rdf.glycoinfo.org/glycan/G49708JS" denotes Thr
GlycanIUPAC_T54 389-392 "http://rdf.glycoinfo.org/glycan/G63317ON" denotes Thr
GlycanIUPAC_T55 389-392 "http://rdf.glycoinfo.org/glycan/G60349YI" denotes Thr
GlycanIUPAC_T56 389-392 "http://rdf.glycoinfo.org/glycan/G81659AQ" denotes Thr
GlycanIUPAC_T57 389-392 "http://rdf.glycoinfo.org/glycan/G16289GE" denotes Thr
GlycanIUPAC_T58 389-392 "http://rdf.glycoinfo.org/glycan/G69569AG" denotes Thr
GlycanIUPAC_T59 389-392 "http://rdf.glycoinfo.org/glycan/G16884LK" denotes Thr
GlycanIUPAC_T60 389-392 "http://rdf.glycoinfo.org/glycan/G23450NH" denotes Thr
GlycanIUPAC_T61 389-392 "http://rdf.glycoinfo.org/glycan/G85052FR" denotes Thr
GlycanIUPAC_T62 389-392 "http://rdf.glycoinfo.org/glycan/G55485RI" denotes Thr
GlycanIUPAC_T63 389-392 "http://rdf.glycoinfo.org/glycan/G80596GL" denotes Thr
GlycanIUPAC_T64 389-392 "http://rdf.glycoinfo.org/glycan/G39656RU" denotes Thr
GlycanIUPAC_T65 389-392 "http://rdf.glycoinfo.org/glycan/G71284FA" denotes Thr
GlycanIUPAC_T66 389-392 "http://rdf.glycoinfo.org/glycan/G42091PK" denotes Thr
GlycanIUPAC_T67 389-392 "http://rdf.glycoinfo.org/glycan/G38798SL" denotes Thr
GlycanIUPAC_T68 389-392 "http://rdf.glycoinfo.org/glycan/G36670NA" denotes Thr
GlycanIUPAC_T69 389-392 "http://rdf.glycoinfo.org/glycan/G91582QV" denotes Thr
GlycanIUPAC_T70 389-392 "http://rdf.glycoinfo.org/glycan/G28625IE" denotes Thr
GlycanIUPAC_T71 389-392 "http://rdf.glycoinfo.org/glycan/G81304ZT" denotes Thr
GlycanIUPAC_T72 389-392 "http://rdf.glycoinfo.org/glycan/G82883BK" denotes Thr
GlycanIUPAC_T73 389-392 "http://rdf.glycoinfo.org/glycan/G46290DK" denotes Thr
GlycanIUPAC_T74 389-392 "http://rdf.glycoinfo.org/glycan/G68202TJ" denotes Thr
GlycanIUPAC_T75 389-392 "http://rdf.glycoinfo.org/glycan/G39722QK" denotes Thr
GlycanIUPAC_T76 389-392 "http://rdf.glycoinfo.org/glycan/G76637LW" denotes Thr
GlycanIUPAC_T77 389-392 "http://rdf.glycoinfo.org/glycan/G51390WF" denotes Thr
GlycanIUPAC_T78 389-392 "http://rdf.glycoinfo.org/glycan/G35392PX" denotes Thr
GlycanIUPAC_T79 389-392 "http://rdf.glycoinfo.org/glycan/G27815EZ" denotes Thr
GlycanIUPAC_T80 389-392 "http://rdf.glycoinfo.org/glycan/G64374OT" denotes Thr
GlycanIUPAC_T81 389-392 "http://rdf.glycoinfo.org/glycan/G58333PU" denotes Thr
GlycanIUPAC_T82 389-392 "http://rdf.glycoinfo.org/glycan/G19695IE" denotes Thr
GlycanIUPAC_T83 389-392 "http://rdf.glycoinfo.org/glycan/G65617GK" denotes Thr
GlycanIUPAC_T84 389-392 "http://rdf.glycoinfo.org/glycan/G29832KZ" denotes Thr
GlycanIUPAC_T85 389-392 "http://rdf.glycoinfo.org/glycan/G05333AM" denotes Thr
GlycanIUPAC_T86 389-392 "http://rdf.glycoinfo.org/glycan/G46130CG" denotes Thr
GlycanIUPAC_T87 389-392 "http://rdf.glycoinfo.org/glycan/G57766RG" denotes Thr
GlycanIUPAC_T88 389-392 "http://rdf.glycoinfo.org/glycan/G03334HH" denotes Thr
GlycanIUPAC_T89 389-392 "http://rdf.glycoinfo.org/glycan/G46094SV" denotes Thr
GlycanIUPAC_T90 389-392 "http://rdf.glycoinfo.org/glycan/G98365FX" denotes Thr
GlycanIUPAC_T91 389-392 "http://rdf.glycoinfo.org/glycan/G85392EJ" denotes Thr
GlycanIUPAC_T92 389-392 "http://rdf.glycoinfo.org/glycan/G59996WL" denotes Thr
GlycanIUPAC_T93 389-392 "http://rdf.glycoinfo.org/glycan/G49141OD" denotes Thr
GlycanIUPAC_T94 389-392 "http://rdf.glycoinfo.org/glycan/G88793VU" denotes Thr
GlycanIUPAC_T95 389-392 "http://rdf.glycoinfo.org/glycan/G88801WQ" denotes Thr
GlycanIUPAC_T96 389-392 "http://rdf.glycoinfo.org/glycan/G61612EQ" denotes Thr
GlycanIUPAC_T97 389-392 "http://rdf.glycoinfo.org/glycan/G23181BS" denotes Thr
GlycanIUPAC_T98 389-392 "http://rdf.glycoinfo.org/glycan/G77428YW" denotes Thr
GlycanIUPAC_T99 389-392 "http://rdf.glycoinfo.org/glycan/G06824UZ" denotes Thr
GlycanIUPAC_T100 389-392 "http://rdf.glycoinfo.org/glycan/G15142RK" denotes Thr
GlycanIUPAC_T101 389-392 "http://rdf.glycoinfo.org/glycan/G18198RM" denotes Thr
GlycanIUPAC_T102 389-392 "http://rdf.glycoinfo.org/glycan/G70750SS" denotes Thr
GlycanIUPAC_T103 389-392 "http://rdf.glycoinfo.org/glycan/G04998YJ" denotes Thr
GlycanIUPAC_T104 389-392 "http://rdf.glycoinfo.org/glycan/G44379HX" denotes Thr
GlycanIUPAC_T105 389-392 "http://rdf.glycoinfo.org/glycan/G25683ZO" denotes Thr
GlycanIUPAC_T106 389-392 "http://rdf.glycoinfo.org/glycan/G35036BA" denotes Thr
GlycanIUPAC_T107 389-392 "http://rdf.glycoinfo.org/glycan/G98129RB" denotes Thr
GlycanIUPAC_T108 389-392 "http://rdf.glycoinfo.org/glycan/G00134PL" denotes Thr
GlycanIUPAC_T109 389-392 "http://rdf.glycoinfo.org/glycan/G26488SP" denotes Thr
GlycanIUPAC_T110 389-392 "http://rdf.glycoinfo.org/glycan/G02441UD" denotes Thr
GlycanIUPAC_T111 389-392 "http://rdf.glycoinfo.org/glycan/G21668ZD" denotes Thr
GlycanIUPAC_T112 389-392 "http://rdf.glycoinfo.org/glycan/G67040OT" denotes Thr
GlycanIUPAC_T113 389-392 "http://rdf.glycoinfo.org/glycan/G56431YZ" denotes Thr
GlycanIUPAC_T114 389-392 "http://rdf.glycoinfo.org/glycan/G29667IS" denotes Thr
GlycanIUPAC_T115 389-392 "http://rdf.glycoinfo.org/glycan/G94122LM" denotes Thr
GlycanIUPAC_T116 389-392 "http://rdf.glycoinfo.org/glycan/G93233YT" denotes Thr
GlycanIUPAC_T117 389-392 "http://rdf.glycoinfo.org/glycan/G72035WK" denotes Thr
GlycanIUPAC_T118 389-392 "http://rdf.glycoinfo.org/glycan/G99855SM" denotes Thr
GlycanIUPAC_T119 389-392 "http://rdf.glycoinfo.org/glycan/G48723MN" denotes Thr
GlycanIUPAC_T120 389-392 "http://rdf.glycoinfo.org/glycan/G28558MB" denotes Thr
GlycanIUPAC_T121 389-392 "http://rdf.glycoinfo.org/glycan/G92768RX" denotes Thr
GlycanIUPAC_T122 389-392 "http://rdf.glycoinfo.org/glycan/G70136KU" denotes Thr
GlycanIUPAC_T123 389-392 "http://rdf.glycoinfo.org/glycan/G37935YM" denotes Thr
GlycanIUPAC_T124 389-392 "http://rdf.glycoinfo.org/glycan/G96902PQ" denotes Thr
GlycanIUPAC_T125 389-392 "http://rdf.glycoinfo.org/glycan/G14015DN" denotes Thr
GlycanIUPAC_T126 389-392 "http://rdf.glycoinfo.org/glycan/G83153IV" denotes Thr
GlycanIUPAC_T127 389-392 "http://rdf.glycoinfo.org/glycan/G73174QP" denotes Thr
GlycanIUPAC_T128 389-392 "http://rdf.glycoinfo.org/glycan/G67188XY" denotes Thr
GlycanIUPAC_T129 389-392 "http://rdf.glycoinfo.org/glycan/G35093GE" denotes Thr
GlycanIUPAC_T130 389-392 "http://rdf.glycoinfo.org/glycan/G13364VQ" denotes Thr
GlycanIUPAC_T131 389-392 "http://rdf.glycoinfo.org/glycan/G72068FB" denotes Thr
GlycanIUPAC_T132 389-392 "http://rdf.glycoinfo.org/glycan/G93329DU" denotes Thr
GlycanIUPAC_T133 389-392 "http://rdf.glycoinfo.org/glycan/G54073VB" denotes Thr
GlycanIUPAC_T134 389-392 "http://rdf.glycoinfo.org/glycan/G41447UI" denotes Thr
GlycanIUPAC_T135 389-392 "http://rdf.glycoinfo.org/glycan/G85878MY" denotes Thr
GlycanIUPAC_T136 389-392 "http://rdf.glycoinfo.org/glycan/G92835HR" denotes Thr
GlycanIUPAC_T137 389-392 "http://rdf.glycoinfo.org/glycan/G34845TQ" denotes Thr
GlycanIUPAC_T138 389-392 "http://rdf.glycoinfo.org/glycan/G38916XK" denotes Thr
GlycanIUPAC_T139 389-392 "http://rdf.glycoinfo.org/glycan/G87709OA" denotes Thr
GlycanIUPAC_T140 389-392 "http://rdf.glycoinfo.org/glycan/G46661GX" denotes Thr
GlycanIUPAC_T141 389-392 "http://rdf.glycoinfo.org/glycan/G53431DX" denotes Thr
GlycanIUPAC_T142 389-392 "http://rdf.glycoinfo.org/glycan/G71815PL" denotes Thr
GlycanIUPAC_T143 389-392 "http://rdf.glycoinfo.org/glycan/G97173UR" denotes Thr
GlycanIUPAC_T144 389-392 "http://rdf.glycoinfo.org/glycan/G53453JD" denotes Thr
GlycanIUPAC_T145 389-392 "http://rdf.glycoinfo.org/glycan/G48975CP" denotes Thr
GlycanIUPAC_T146 389-392 "http://rdf.glycoinfo.org/glycan/G87775XT" denotes Thr
GlycanIUPAC_T147 389-392 "http://rdf.glycoinfo.org/glycan/G48463GY" denotes Thr
GlycanIUPAC_T148 389-392 "http://rdf.glycoinfo.org/glycan/G54042BQ" denotes Thr
GlycanIUPAC_T149 389-392 "http://rdf.glycoinfo.org/glycan/G99993MV" denotes Thr
GlycanIUPAC_T150 389-392 "http://rdf.glycoinfo.org/glycan/G81407LL" denotes Thr
GlycanIUPAC_T151 389-392 "http://rdf.glycoinfo.org/glycan/G46430YF" denotes Thr
GlycanIUPAC_T152 389-392 "http://rdf.glycoinfo.org/glycan/G86548QQ" denotes Thr
GlycanIUPAC_T153 389-392 "http://rdf.glycoinfo.org/glycan/G25645HZ" denotes Thr
GlycanIUPAC_T154 389-392 "http://rdf.glycoinfo.org/glycan/G73880WZ" denotes Thr
GlycanIUPAC_T155 389-392 "http://rdf.glycoinfo.org/glycan/G12979RT" denotes Thr
GlycanIUPAC_T156 389-392 "http://rdf.glycoinfo.org/glycan/G36146RU" denotes Thr
GlycanIUPAC_T157 389-392 "http://rdf.glycoinfo.org/glycan/G23944RZ" denotes Thr
GlycanIUPAC_T158 389-392 "http://rdf.glycoinfo.org/glycan/G67041BN" denotes Thr
GlycanIUPAC_T159 389-392 "http://rdf.glycoinfo.org/glycan/G95408HX" denotes Thr
GlycanIUPAC_T160 389-392 "http://rdf.glycoinfo.org/glycan/G31094CC" denotes Thr
GlycanIUPAC_T161 389-392 "http://rdf.glycoinfo.org/glycan/G99598GU" denotes Thr
GlycanIUPAC_T162 389-392 "http://rdf.glycoinfo.org/glycan/G94072IC" denotes Thr
GlycanIUPAC_T163 389-392 "http://rdf.glycoinfo.org/glycan/G09523ZS" denotes Thr

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 526-532 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 519-524 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colon
PD-UBERON-AE-B_T3 692-697 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colon

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 537-551 Disease denotes ovarian cancer http://purl.obolibrary.org/obo/MONDO_0008170
T2 605-610 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070
T3 692-704 Disease denotes colon cancer http://purl.obolibrary.org/obo/MONDO_0021063
T4 1566-1572 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 374-380 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 537-551 Phenotype denotes ovarian cancer HP:0100615
T2 605-610 Phenotype denotes tumor HP:0002664
T3 692-704 Phenotype denotes colon cancer HP:0003003
T4 1566-1572 Phenotype denotes cancer HP:0002664

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 374-380 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 537-551 Phenotype denotes ovarian cancer HP:0100615
T2 605-610 Phenotype denotes tumor HP:0002664
T3 692-704 Phenotype denotes colon cancer HP:0003003
T4 1566-1572 Phenotype denotes cancer HP:0002664

GlyCosmos15-CL

Id Subject Object Predicate Lexical cue cl_id
T1 545-557 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064
T2 1566-1578 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 519-524 Body_part denotes colon http://purl.obolibrary.org/obo/UBERON_0001155
T2 526-532 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T3 692-697 Body_part denotes colon http://purl.obolibrary.org/obo/UBERON_0001155
T4 935-945 Body_part denotes cell cycle http://purl.obolibrary.org/obo/UBERON_2000098
T5 1164-1174 Body_part denotes cell cycle http://purl.obolibrary.org/obo/UBERON_2000098

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 537-551 Disease denotes ovarian cancer MONDO:0005140|MONDO:0008170
T3 605-610 Disease denotes tumor MONDO:0005070
T4 692-704 Disease denotes colon cancer MONDO:0002032|MONDO:0005575|MONDO:0021063
T7 1566-1572 Disease denotes cancer MONDO:0004992

GlyCosmos15-Taxon

Id Subject Object Predicate Lexical cue db_id
T1 44-62 Organism denotes Sclerotium rolfsii 39291
T2 194-212 Organism denotes Sclerotium rolfsii 39291
T3 443-448 Organism denotes human 9606
T4 513-518 Organism denotes human 9606
T5 686-691 Organism denotes human 9606

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-193 Sentence denotes Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.
T2 194-457 Sentence denotes Sclerotium rolfsii lectin (SRL) is a lectin isolated from fungus S. rolfsii and has high binding specificity toward the oncofetal Thomsen-Friedenreich carbohydrate antigen (Galβ1-3GalNAc-α-O-Ser/Thr, T or TF), which is expressed in more than 90% of human cancers.
T3 458-626 Sentence denotes Our previous studies have shown that binding of SRL to human colon, breast and ovarian cancer cells induces cell apoptosis in vitro and suppresses tumor growth in vivo.
T4 627-746 Sentence denotes This study investigated the SRL-mediated cell signaling in human colon cancer HT29 cells by mRNA and miRNA microarrays.
T5 747-997 Sentence denotes It was found that SRL treatment results in altered expression of several hundred molecules including mitogen-activated protein kinase (MAPK) and c-JUN-associated, apoptosis-associated and cell cycle and DNA replication-associated signaling molecules.
T6 998-1259 Sentence denotes Pathway analysis using GeneSpring 12.6.1 revealed that SRL treatment induces changes of MAPK and c-JUN-associated signaling pathways as early as 2 h while changes of cell cycle, DNA replication and apoptosis pathways were significantly affected only after 24 h.
T7 1260-1367 Sentence denotes A significant change of cell miRNA expression was also observed after 12 h treatment of the cells with SRL.
T8 1368-1476 Sentence denotes These changes were further validated by quantitative real time polymerase chain reaction and immunoblotting.
T9 1477-1718 Sentence denotes This study thus suggests that the presence of SRL affects multiple signaling pathways in cancer cells with early effects on cell proliferation pathways associated with MAPK and c-JUN, followed by miRNA-associated cell activity and apoptosis.
T10 1719-1831 Sentence denotes This provides insight information into the molecular mechanism of the anticancer activity of this fungal lectin.

Lectin-Jamboree-Sentence

Id Subject Object Predicate Lexical cue
T1 0-193 Sentence denotes Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.
T2 194-457 Sentence denotes Sclerotium rolfsii lectin (SRL) is a lectin isolated from fungus S. rolfsii and has high binding specificity toward the oncofetal Thomsen-Friedenreich carbohydrate antigen (Galβ1-3GalNAc-α-O-Ser/Thr, T or TF), which is expressed in more than 90% of human cancers.
T3 458-626 Sentence denotes Our previous studies have shown that binding of SRL to human colon, breast and ovarian cancer cells induces cell apoptosis in vitro and suppresses tumor growth in vivo.
T4 627-746 Sentence denotes This study investigated the SRL-mediated cell signaling in human colon cancer HT29 cells by mRNA and miRNA microarrays.
T5 747-997 Sentence denotes It was found that SRL treatment results in altered expression of several hundred molecules including mitogen-activated protein kinase (MAPK) and c-JUN-associated, apoptosis-associated and cell cycle and DNA replication-associated signaling molecules.
T6 998-1259 Sentence denotes Pathway analysis using GeneSpring 12.6.1 revealed that SRL treatment induces changes of MAPK and c-JUN-associated signaling pathways as early as 2 h while changes of cell cycle, DNA replication and apoptosis pathways were significantly affected only after 24 h.
T7 1260-1367 Sentence denotes A significant change of cell miRNA expression was also observed after 12 h treatment of the cells with SRL.
T8 1368-1476 Sentence denotes These changes were further validated by quantitative real time polymerase chain reaction and immunoblotting.
T9 1477-1718 Sentence denotes This study thus suggests that the presence of SRL affects multiple signaling pathways in cancer cells with early effects on cell proliferation pathways associated with MAPK and c-JUN, followed by miRNA-associated cell activity and apoptosis.
T10 1719-1831 Sentence denotes This provides insight information into the molecular mechanism of the anticancer activity of this fungal lectin.

GlyCosmos15-FMA

Id Subject Object Predicate Lexical cue db_id
T1 519-524 Body_part denotes colon FMA:14543
T2 526-532 Body_part denotes breast FMA:9601
T3 692-697 Body_part denotes colon FMA:14543

GlyCosmos15-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 519-524 Body_part denotes colon http://purl.obolibrary.org/obo/MAT_0000526
T2 692-697 Body_part denotes colon http://purl.obolibrary.org/obo/MAT_0000526

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 44-62 OrganismTaxon denotes Sclerotium rolfsii 39291
T2 194-212 OrganismTaxon denotes Sclerotium rolfsii 39291
T3 443-448 OrganismTaxon denotes human 9606
T4 513-518 OrganismTaxon denotes human 9606
T5 686-691 OrganismTaxon denotes human 9606

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 519-524 Body_part denotes colon http://purl.obolibrary.org/obo/UBERON_0001155
T2 526-532 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T3 692-697 Body_part denotes colon http://purl.obolibrary.org/obo/UBERON_0001155
T4 935-945 Body_part denotes cell cycle http://purl.obolibrary.org/obo/UBERON_2000098
T5 1164-1174 Body_part denotes cell cycle http://purl.obolibrary.org/obo/UBERON_2000098

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 519-524 Body_part denotes colon http://purl.obolibrary.org/obo/MAT_0000526
T2 692-697 Body_part denotes colon http://purl.obolibrary.org/obo/MAT_0000526

CL-cell

Id Subject Object Predicate Lexical cue cl_id
T1 545-557 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064
T2 1566-1578 Cell denotes cancer cells http://purl.obolibrary.org/obo/CL:0001064